Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGION BIOMEDICA CORP.

(ANGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Angion Biomedica : Stifel Starts Angion Biomedica at Buy With $40 Price Target

03/02/2021 | 07:45am EDT


© MT Newswires 2021
All news about ANGION BIOMEDICA CORP.
10/18ANGION BIOMEDICA : to Present Multiple Posters at Kidney Week 2021
AQ
09/08ANGION BIOMEDICA : Hosting Research & Development Day on ANG-3070 for the Treatment of Lun..
AQ
09/02ANGION BIOMEDICA : to Participate in Upcoming September Investment Conferences
AQ
08/30ANGION BIOMEDICA : Termination of Material Definitive Agreement (Form 8-K)
PU
08/30ANGION BIOMEDICA CORP. : Termination of a Material Definitive Agreement (form 8-K)
AQ
08/30Sinovant Sciences HK Limited Intends to Terminate Its Exclusive License Agreement with ..
CI
08/12ANGION BIOMEDICA : Provides Corporate Update and Reports Second Quarter 2021 Financial Res..
PU
08/12ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q2 Revenue $540,000
MT
08/12ANGION BIOMEDICA : Earnings Flash (ANGN) ANGION BIOMEDICA Reports Q2 Loss $-0.58
MT
08/12ANGION BIOMEDICA CORP. : Results of Operations and Financial Condition, Financial Statemen..
AQ
More news
Analyst Recommendations on ANGION BIOMEDICA CORP.
More recommendations
Financials (USD)
Sales 2021 3,30 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 255 M 255 M -
Capi. / Sales 2021 77,5x
Capi. / Sales 2022 19,4x
Nbr of Employees 72
Free-Float 59,4%
Chart ANGION BIOMEDICA CORP.
Duration : Period :
Angion Biomedica Corp. Technical Analysis Chart | ANGN | US03476J1079 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 8,57 $
Average target price 59,33 $
Spread / Average Target 592%
Managers and Directors
Jay R. Venkatesan President, Chief Executive Officer & Director
Greg S. Curhan Chief Financial Officer
Itzhak D. Goldberg Executive Chairman & Chief Scientific Officer
John F. Neylan Chief Medical Officer & Senior Vice President
Jennifer J. Rhodes Secretary, Chief Compliance Office & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
ANGION BIOMEDICA CORP.0.00%255
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 076
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455